Pictet Asset Management (Switzerland)’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-101,717
| Closed | -$1.34M | – | 2003 |
|
|
2022
Q3 | $1.34M | Sell |
101,717
-93,903
| -48% | -$1.24M | ﹤0.01% | 970 |
|
|
2022
Q2 | $2.47M | Buy |
195,620
+93,523
| +92% | +$1.18M | ﹤0.01% | 901 |
|
|
2022
Q1 | $5.87M | Buy |
102,097
+3,372
| +3% | +$194K | 0.01% | 775 |
|
|
2021
Q4 | $11.7M | Sell |
98,725
-2,587
| -3% | -$307K | 0.01% | 623 |
|
|
2021
Q3 | $20.1M | Buy |
+101,312
| New | +$20.1M | 0.02% | 509 |
|